FI841154A - Kromon- och tiokromonsubstituerade 1,4- dihydropyridinderivat, flera foerfaranden foer deras framstaellning och deras anvaendning i laekemedel. - Google Patents

Kromon- och tiokromonsubstituerade 1,4- dihydropyridinderivat, flera foerfaranden foer deras framstaellning och deras anvaendning i laekemedel. Download PDF

Info

Publication number
FI841154A
FI841154A FI841154A FI841154A FI841154A FI 841154 A FI841154 A FI 841154A FI 841154 A FI841154 A FI 841154A FI 841154 A FI841154 A FI 841154A FI 841154 A FI841154 A FI 841154A
Authority
FI
Finland
Prior art keywords
deras
thiochromons
dihydropyridinderivat
laekemedel
chromon
Prior art date
Application number
FI841154A
Other languages
English (en)
Other versions
FI82463C (fi
FI841154A0 (fi
FI82463B (fi
Inventor
Siegfried Goldmann
Gerhard Franckowiak
Matthias Schramm
Guenter Thomas
Rainer Gross
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI841154A0 publication Critical patent/FI841154A0/fi
Publication of FI841154A publication Critical patent/FI841154A/fi
Application granted granted Critical
Publication of FI82463B publication Critical patent/FI82463B/fi
Publication of FI82463C publication Critical patent/FI82463C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI841154A 1983-03-25 1984-03-22 Foerfarande foer framstaellning av terapeutiskt anvaendbara dihydropyridiner. FI82463C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833311005 DE3311005A1 (de) 1983-03-25 1983-03-25 Chromon- und thiochromonsubstituierte 1,4-dihydropyridinderivate, mehrere verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3311005 1983-03-25

Publications (4)

Publication Number Publication Date
FI841154A0 FI841154A0 (fi) 1984-03-22
FI841154A true FI841154A (fi) 1984-09-26
FI82463B FI82463B (fi) 1990-11-30
FI82463C FI82463C (fi) 1991-03-11

Family

ID=6194712

Family Applications (1)

Application Number Title Priority Date Filing Date
FI841154A FI82463C (fi) 1983-03-25 1984-03-22 Foerfarande foer framstaellning av terapeutiskt anvaendbara dihydropyridiner.

Country Status (14)

Country Link
US (1) US4540789A (fi)
EP (1) EP0123112B1 (fi)
JP (1) JPS59176281A (fi)
KR (1) KR910007973B1 (fi)
AT (1) ATE37367T1 (fi)
AU (1) AU558035B2 (fi)
CA (1) CA1236460A (fi)
DE (2) DE3311005A1 (fi)
DK (1) DK163733B (fi)
ES (4) ES8607290A1 (fi)
FI (1) FI82463C (fi)
HU (1) HU191302B (fi)
NO (1) NO840951L (fi)
ZA (1) ZA842165B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
IT1190405B (it) * 1985-10-22 1988-02-16 Recordati Chem Pharm Derivati del flavone
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
IN164232B (fi) * 1986-04-11 1989-02-04 Hoechst India
DE3712369A1 (de) * 1987-04-11 1988-10-27 Bayer Ag Substituierte 5-nitro-1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung
US5045551A (en) * 1989-09-19 1991-09-03 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
DE4011105A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5204472A (en) * 1990-04-06 1993-04-20 Bayer Aktiengesellschaft Quinoline and isoquinoline intermediates
JPH0413679A (ja) * 1990-05-07 1992-01-17 Wakunaga Pharmaceut Co Ltd 新規ジヒドロピリジン誘導体
DE4321030A1 (de) * 1993-06-24 1995-01-05 Bayer Ag 4-bicyclisch substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimittel
DE102005034267A1 (de) 2005-07-22 2007-01-25 Bayer Healthcare Ag 4-Chromenonyl-1,4-dihydropyridine und ihre Verwendung
DE102005034264A1 (de) * 2005-07-22 2007-02-01 Bayer Healthcare Ag 4-Chromenonyl-1,4-dihydropyridincarbonitrile und ihre Verwendung
DE102006026585A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3201406A (en) * 1963-02-11 1965-08-17 Upjohn Co Pyridylcoumarins
DE3412947A1 (de) * 1984-04-06 1985-10-17 Bayer Ag, 5090 Leverkusen Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
HUT34186A (en) 1985-02-28
EP0123112A3 (en) 1987-07-22
AU2591484A (en) 1984-09-27
DK163733B (da) 1992-03-30
ES8705430A1 (es) 1987-05-01
FI82463C (fi) 1991-03-11
DE3474144D1 (en) 1988-10-27
ES552230A0 (es) 1987-05-01
EP0123112A2 (de) 1984-10-31
US4540789A (en) 1985-09-10
HU191302B (en) 1987-02-27
NO840951L (no) 1984-09-26
ATE37367T1 (de) 1988-10-15
KR840008023A (ko) 1984-12-12
KR910007973B1 (ko) 1991-10-05
EP0123112B1 (de) 1988-09-21
ES8607290A1 (es) 1986-06-16
JPH0549671B2 (fi) 1993-07-26
DK145384D0 (da) 1984-02-29
ES8705429A1 (es) 1987-05-01
ES8705428A1 (es) 1987-05-01
JPS59176281A (ja) 1984-10-05
FI841154A0 (fi) 1984-03-22
ES530802A0 (es) 1984-11-01
ZA842165B (en) 1984-10-31
ES552232A0 (es) 1987-05-01
FI82463B (fi) 1990-11-30
CA1236460A (en) 1988-05-10
ES552231A0 (es) 1987-05-01
AU558035B2 (en) 1987-01-15
DE3311005A1 (de) 1984-09-27
DK145384A (da) 1984-09-26

Similar Documents

Publication Publication Date Title
FI841154A (fi) Kromon- och tiokromonsubstituerade 1,4- dihydropyridinderivat, flera foerfaranden foer deras framstaellning och deras anvaendning i laekemedel.
FI841153A0 (fi) Med kromon och tiokromon substituerade 1,4-dihydropyridonlaktoner, flera foerfaranden foer framstaellning av dessa och deras anvaendning i laekemedel.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BAYER AKTIENGESELLSCHAFT